Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Cholera Vaccines Market Growth (Status and Outlook) 2022-2028

  • LP 4851752
  • 103 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cholera Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Cholera Vaccines market size is USD million in 2022 from USD 81 million in 2021, with a change of % between 2021 and 2022. The global Cholera Vaccines market size will reach USD 152.1 million in 2028, growing at a CAGR of 9.3% over the analysis period.

The United States Cholera Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cholera Vaccines market, reaching US$ million by the year 2028. As for the Europe Cholera Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cholera Vaccines players cover Shantha Biotechnics Private Limited, PaxVax, Inc., Valneva SE, and Merck and Co., Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cholera Vaccines market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Dukoral

Shanchol

Vaxchora

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Oral

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Shantha Biotechnics Private Limited

PaxVax, Inc.

Valneva SE

Merck and Co., Inc.

GlaxoSmithKline plc (GSK)

Astellas Pharma, Inc.

Pfizer, Inc.

Emergent BioSolutions, Inc.

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Co., Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cholera Vaccines Market Size 2017-2028

2.1.2 Cholera Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cholera Vaccines Segment by Type

2.2.1 Dukoral

2.2.2 Shanchol

2.2.3 Vaxchora

2.2.4 Others

2.3 Cholera Vaccines Market Size by Type

2.3.1 Cholera Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cholera Vaccines Market Size Market Share by Type (2017-2022)

2.4 Cholera Vaccines Segment by Application

2.4.1 Oral

2.4.2 Others

2.5 Cholera Vaccines Market Size by Application

2.5.1 Cholera Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cholera Vaccines Market Size Market Share by Application (2017-2022)

3 Cholera Vaccines Market Size by Player

3.1 Cholera Vaccines Market Size Market Share by Players

3.1.1 Global Cholera Vaccines Revenue by Players (2020-2022)

3.1.2 Global Cholera Vaccines Revenue Market Share by Players (2020-2022)

3.2 Global Cholera Vaccines Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cholera Vaccines by Regions

4.1 Cholera Vaccines Market Size by Regions (2017-2022)

4.2 Americas Cholera Vaccines Market Size Growth (2017-2022)

4.3 APAC Cholera Vaccines Market Size Growth (2017-2022)

4.4 Europe Cholera Vaccines Market Size Growth (2017-2022)

4.5 Middle East & Africa Cholera Vaccines Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cholera Vaccines Market Size by Country (2017-2022)

5.2 Americas Cholera Vaccines Market Size by Type (2017-2022)

5.3 Americas Cholera Vaccines Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cholera Vaccines Market Size by Region (2017-2022)

6.2 APAC Cholera Vaccines Market Size by Type (2017-2022)

6.3 APAC Cholera Vaccines Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cholera Vaccines by Country (2017-2022)

7.2 Europe Cholera Vaccines Market Size by Type (2017-2022)

7.3 Europe Cholera Vaccines Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cholera Vaccines by Region (2017-2022)

8.2 Middle East & Africa Cholera Vaccines Market Size by Type (2017-2022)

8.3 Middle East & Africa Cholera Vaccines Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cholera Vaccines Market Forecast

10.1 Global Cholera Vaccines Forecast by Regions (2023-2028)

10.1.1 Global Cholera Vaccines Forecast by Regions (2023-2028)

10.1.2 Americas Cholera Vaccines Forecast

10.1.3 APAC Cholera Vaccines Forecast

10.1.4 Europe Cholera Vaccines Forecast

10.1.5 Middle East & Africa Cholera Vaccines Forecast

10.2 Americas Cholera Vaccines Forecast by Country (2023-2028)

10.2.1 United States Cholera Vaccines Market Forecast

10.2.2 Canada Cholera Vaccines Market Forecast

10.2.3 Mexico Cholera Vaccines Market Forecast

10.2.4 Brazil Cholera Vaccines Market Forecast

10.3 APAC Cholera Vaccines Forecast by Region (2023-2028)

10.3.1 China Cholera Vaccines Market Forecast

10.3.2 Japan Cholera Vaccines Market Forecast

10.3.3 Korea Cholera Vaccines Market Forecast

10.3.4 Southeast Asia Cholera Vaccines Market Forecast

10.3.5 India Cholera Vaccines Market Forecast

10.3.6 Australia Cholera Vaccines Market Forecast

10.4 Europe Cholera Vaccines Forecast by Country (2023-2028)

10.4.1 Germany Cholera Vaccines Market Forecast

10.4.2 France Cholera Vaccines Market Forecast

10.4.3 UK Cholera Vaccines Market Forecast

10.4.4 Italy Cholera Vaccines Market Forecast

10.4.5 Russia Cholera Vaccines Market Forecast

10.5 Middle East & Africa Cholera Vaccines Forecast by Region (2023-2028)

10.5.1 Egypt Cholera Vaccines Market Forecast

10.5.2 South Africa Cholera Vaccines Market Forecast

10.5.3 Israel Cholera Vaccines Market Forecast

10.5.4 Turkey Cholera Vaccines Market Forecast

10.5.5 GCC Countries Cholera Vaccines Market Forecast

10.6 Global Cholera Vaccines Forecast by Type (2023-2028)

10.7 Global Cholera Vaccines Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Shantha Biotechnics Private Limited

11.1.1 Shantha Biotechnics Private Limited Company Information

11.1.2 Shantha Biotechnics Private Limited Cholera Vaccines Product Offered

11.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Shantha Biotechnics Private Limited Main Business Overview

11.1.5 Shantha Biotechnics Private Limited Latest Developments

11.2 PaxVax, Inc.

11.2.1 PaxVax, Inc. Company Information

11.2.2 PaxVax, Inc. Cholera Vaccines Product Offered

11.2.3 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 PaxVax, Inc. Main Business Overview

11.2.5 PaxVax, Inc. Latest Developments

11.3 Valneva SE

11.3.1 Valneva SE Company Information

11.3.2 Valneva SE Cholera Vaccines Product Offered

11.3.3 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Valneva SE Main Business Overview

11.3.5 Valneva SE Latest Developments

11.4 Merck and Co., Inc.

11.4.1 Merck and Co., Inc. Company Information

11.4.2 Merck and Co., Inc. Cholera Vaccines Product Offered

11.4.3 Merck and Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Merck and Co., Inc. Main Business Overview

11.4.5 Merck and Co., Inc. Latest Developments

11.5 GlaxoSmithKline plc (GSK)

11.5.1 GlaxoSmithKline plc (GSK) Company Information

11.5.2 GlaxoSmithKline plc (GSK) Cholera Vaccines Product Offered

11.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GlaxoSmithKline plc (GSK) Main Business Overview

11.5.5 GlaxoSmithKline plc (GSK) Latest Developments

11.6 Astellas Pharma, Inc.

11.6.1 Astellas Pharma, Inc. Company Information

11.6.2 Astellas Pharma, Inc. Cholera Vaccines Product Offered

11.6.3 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Astellas Pharma, Inc. Main Business Overview

11.6.5 Astellas Pharma, Inc. Latest Developments

11.7 Pfizer, Inc.

11.7.1 Pfizer, Inc. Company Information

11.7.2 Pfizer, Inc. Cholera Vaccines Product Offered

11.7.3 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Pfizer, Inc. Main Business Overview

11.7.5 Pfizer, Inc. Latest Developments

11.8 Emergent BioSolutions, Inc.

11.8.1 Emergent BioSolutions, Inc. Company Information

11.8.2 Emergent BioSolutions, Inc. Cholera Vaccines Product Offered

11.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Emergent BioSolutions, Inc. Main Business Overview

11.8.5 Emergent BioSolutions, Inc. Latest Developments

11.9 Mitsubishi Tanabe Pharma Corporation

11.9.1 Mitsubishi Tanabe Pharma Corporation Company Information

11.9.2 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Offered

11.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Mitsubishi Tanabe Pharma Corporation Main Business Overview

11.9.5 Mitsubishi Tanabe Pharma Corporation Latest Developments

11.10 Takeda Pharmaceutical Co., Ltd.

11.10.1 Takeda Pharmaceutical Co., Ltd. Company Information

11.10.2 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Offered

11.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Takeda Pharmaceutical Co., Ltd. Main Business Overview

11.10.5 Takeda Pharmaceutical Co., Ltd. Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Cholera Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Dukoral

Table 3. Major Players of Shanchol

Table 4. Major Players of Vaxchora

Table 5. Major Players of Others

Table 6. Cholera Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Cholera Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Cholera Vaccines Market Size Market Share by Type (2017-2022)

Table 9. Cholera Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Cholera Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Cholera Vaccines Market Size Market Share by Application (2017-2022)

Table 12. Global Cholera Vaccines Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Cholera Vaccines Revenue Market Share by Player (2020-2022)

Table 14. Cholera Vaccines Key Players Head office and Products Offered

Table 15. Cholera Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Cholera Vaccines Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Cholera Vaccines Market Size Market Share by Regions (2017-2022)

Table 20. Americas Cholera Vaccines Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Cholera Vaccines Market Size Market Share by Country (2017-2022)

Table 22. Americas Cholera Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Cholera Vaccines Market Size Market Share by Type (2017-2022)

Table 24. Americas Cholera Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Cholera Vaccines Market Size Market Share by Application (2017-2022)

Table 26. APAC Cholera Vaccines Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Cholera Vaccines Market Size Market Share by Region (2017-2022)

Table 28. APAC Cholera Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Cholera Vaccines Market Size Market Share by Type (2017-2022)

Table 30. APAC Cholera Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Cholera Vaccines Market Size Market Share by Application (2017-2022)

Table 32. Europe Cholera Vaccines Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Cholera Vaccines Market Size Market Share by Country (2017-2022)

Table 34. Europe Cholera Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Cholera Vaccines Market Size Market Share by Type (2017-2022)

Table 36. Europe Cholera Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Cholera Vaccines Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Cholera Vaccines Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Cholera Vaccines Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Cholera Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Cholera Vaccines Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Cholera Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Cholera Vaccines Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Cholera Vaccines

Table 45. Key Market Challenges & Risks of Cholera Vaccines

Table 46. Key Industry Trends of Cholera Vaccines

Table 47. Global Cholera Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Cholera Vaccines Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Cholera Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Cholera Vaccines Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Cholera Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Cholera Vaccines Market Size Market Share Forecast by Application (2023-2028)

Table 53. Shantha Biotechnics Private Limited Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 54. Shantha Biotechnics Private Limited Cholera Vaccines Product Offered

Table 55. Shantha Biotechnics Private Limited Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Shantha Biotechnics Private Limited Main Business

Table 57. Shantha Biotechnics Private Limited Latest Developments

Table 58. PaxVax, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 59. PaxVax, Inc. Cholera Vaccines Product Offered

Table 60. PaxVax, Inc. Main Business

Table 61. PaxVax, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. PaxVax, Inc. Latest Developments

Table 63. Valneva SE Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 64. Valneva SE Cholera Vaccines Product Offered

Table 65. Valneva SE Main Business

Table 66. Valneva SE Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Valneva SE Latest Developments

Table 68. Merck and Co., Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 69. Merck and Co., Inc. Cholera Vaccines Product Offered

Table 70. Merck and Co., Inc. Main Business

Table 71. Merck and Co., Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Merck and Co., Inc. Latest Developments

Table 73. GlaxoSmithKline plc (GSK) Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 74. GlaxoSmithKline plc (GSK) Cholera Vaccines Product Offered

Table 75. GlaxoSmithKline plc (GSK) Main Business

Table 76. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. GlaxoSmithKline plc (GSK) Latest Developments

Table 78. Astellas Pharma, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 79. Astellas Pharma, Inc. Cholera Vaccines Product Offered

Table 80. Astellas Pharma, Inc. Main Business

Table 81. Astellas Pharma, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Astellas Pharma, Inc. Latest Developments

Table 83. Pfizer, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 84. Pfizer, Inc. Cholera Vaccines Product Offered

Table 85. Pfizer, Inc. Main Business

Table 86. Pfizer, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Pfizer, Inc. Latest Developments

Table 88. Emergent BioSolutions, Inc. Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 89. Emergent BioSolutions, Inc. Cholera Vaccines Product Offered

Table 90. Emergent BioSolutions, Inc. Main Business

Table 91. Emergent BioSolutions, Inc. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Emergent BioSolutions, Inc. Latest Developments

Table 93. Mitsubishi Tanabe Pharma Corporation Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 94. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product Offered

Table 95. Mitsubishi Tanabe Pharma Corporation Main Business

Table 96. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Mitsubishi Tanabe Pharma Corporation Latest Developments

Table 98. Takeda Pharmaceutical Co., Ltd. Details, Company Type, Cholera Vaccines Area Served and Its Competitors

Table 99. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product Offered

Table 100. Takeda Pharmaceutical Co., Ltd. Main Business

Table 101. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Takeda Pharmaceutical Co., Ltd. Latest Developments

List of Figures

Figure 1. Cholera Vaccines Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cholera Vaccines Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cholera Vaccines Market Size Market Share by Type in 2021

Figure 7. Cholera Vaccines in Oral

Figure 8. Global Cholera Vaccines Market: Oral (2017-2022) & ($ Millions)

Figure 9. Cholera Vaccines in Others

Figure 10. Global Cholera Vaccines Market: Others (2017-2022) & ($ Millions)

Figure 11. Global Cholera Vaccines Market Size Market Share by Application in 2021

Figure 12. Global Cholera Vaccines Revenue Market Share by Player in 2021

Figure 13. Global Cholera Vaccines Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Cholera Vaccines Market Size 2017-2022 ($ Millions)

Figure 15. APAC Cholera Vaccines Market Size 2017-2022 ($ Millions)

Figure 16. Europe Cholera Vaccines Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Cholera Vaccines Market Size 2017-2022 ($ Millions)

Figure 18. Americas Cholera Vaccines Value Market Share by Country in 2021

Figure 19. Americas Cholera Vaccines Consumption Market Share by Type in 2021

Figure 20. Americas Cholera Vaccines Market Size Market Share by Application in 2021

Figure 21. United States Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Cholera Vaccines Market Size Market Share by Region in 2021

Figure 26. APAC Cholera Vaccines Market Size Market Share by Application in 2021

Figure 27. China Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Cholera Vaccines Market Size Market Share by Country in 2021

Figure 34. Europe Cholera Vaccines Market Size Market Share by Type in 2021

Figure 35. Europe Cholera Vaccines Market Size Market Share by Application in 2021

Figure 36. Germany Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Cholera Vaccines Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Cholera Vaccines Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Cholera Vaccines Market Size Market Share by Application in 2021

Figure 44. Egypt Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Cholera Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 50. APAC Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 51. Europe Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 53. United States Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 54. Canada Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 57. China Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 58. Japan Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 59. Korea Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 61. India Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 62. Australia Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 63. Germany Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 64. France Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 65. UK Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 66. Italy Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 67. Russia Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 68. Spain Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 71. Israel Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Cholera Vaccines Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Cholera Vaccines Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450